Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mucositis × Rituximab × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Lymphoma 234 Lymphoma, Non-Hodgkin 181 Leukemia, Lymphocytic, Chronic, B-Cell 171 Lymphoma, Large B-Cell, Diffuse 164 Lymphoma, Follicular 152 Lymphoma, Mantle-Cell 117 Leukemia 76 Lymphoma, B-Cell, Marginal Zone 71 Waldenstrom Macroglobulinemia 50 Burkitt Lymphoma 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Lymphoma, Large-Cell, Immunoblastic 39 Lymphoma, B-Cell 39 Hodgkin Disease 36 Recurrence 32 Lymphoma, Large-Cell, Anaplastic 15 Multiple Myeloma 14 Neoplasms 12 Myelodysplastic Syndromes 12 Hematologic Neoplasms 12 Leukemia, Myeloid, Acute 11 Intraocular Lymphoma 8 Dendritic Cell Sarcoma, Interdigitating 8 Leukemia, Prolymphocytic 7 Lymphoma, T-Cell 6 Leukemia, B-Cell 6 Neoplasms, Plasma Cell 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Arthritis, Rheumatoid 5 Myeloproliferative Disorders 4

Interventions

Radiotherapy 5 Injections 3 Fibroblast Growth Factor 7 3 Drug Therapy 3 Xylitol 2 Water 2 Propolis 2 Mouthwashes 2 Morphine 2 Methotrexate 2 Melphalan 2 Interleukin 1 Receptor Antagonist Protein 2 Gabapentin 2 Cisplatin 2 peppermint oil 1 pegaspargase 1 oxycodone-acetaminophen 1 nelarabine 1 kang-lai-te 1 glucarpidase 1 fludarabine phosphate 1 fish oil triglycerides 1 cyclohexaneacetic acid 1 calcium phosphate 1 brilacidin 1 anise oil 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 acetaminophen, hydrocodone drug combination 1 Whole-Body Irradiation 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡